Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › Billing code J7686

J7686

Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg

Medicaid paid $16.82M on code J7686 from 2018 through 2024, to 3 providers — the #1,651 code in the file by dollars. 74% of it was billed in Pennsylvania.

28Total paid$16.82M
24GClaims5,698
Paid per claim line$3K
33Providers billing it3
Box 32 · Location

Where J7686 is billed

  1. $12M
  2. $2.8M
  3. $1.5M

The largest of 3 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.

Ranked

Top providers billing J7686

#ProviderLocationClaimsPaid on J7686
1 Accredo Health Group INC Warrendale, PA 3,664 $12.48M
2 Accredo Health Group INC Memphis, TN 1,589 $2.82M
3 Accredo Health Group INC Corona, CA 445 $1.52M